Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.


News  


November 13, 2014

Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.

 

 

> Read more



June 4, 2013

Uman Pharma is pleased to announce that it has successfully passed its inspection by the United States Food and Drug Administration (FDA).

 

 

> Read more



November 9, 2011

Uman Pharma Inc., a Canadian privately owned generic pharmaceutical company is pleased to announce the conclusion of a strategic partnership with CFR Pharmaceuticals S. A. (CFR) of Santiago, Chile.

 

> Read more



April 27, 2010

Under the terms of the agreement, Antares and Uman will invest jointly to develop and commercialize VIBEXTM MTX, Antares' novel pressure-assisted injection device, containing methotrexate for rheumatoid arthritis and related autoimmune conditions in the US and Canada.

 

> Read more



April 14, 2009

Uman Pharma is proud to announce the receipt of the Establishment Licence from Health Canada for the production and packaging of sterile and solid oral dosage pharmaceutical products.

 

 

> Read more



October 23, 2008

Uman Pharma is offering the newly generic EPIRUBICIN drug in Canada.

> Read more



May 1, 2008

Uman Pharma is proud to announce the acquisition of the Bristol Myers-Squibb facility in Candiac (Canada).

> Read more






Pharmascience Inc.

100, de l'Industrie Boulevard, Candiac, Québec, Canada, J5R 1J1

(450) 444-9989 / 1 877 444-9989


Contact us


© 2017 Pharmascience inc. All rights reserved. Website design by Vortex Solution